PRESS RELEASE published on 07/24/2025 at 18:00, 4 months 12 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 7 bonds in Oxurion, leading to EUR 175,000 capital increase. Oxurion focuses on therapeutic innovation to preserve elderly vision Capital Increase Atlas Special Opportunities Oxurion Therapeutic Innovation Vision Preservation
PRESS RELEASE published on 07/24/2025 at 18:00, 4 months 12 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converteert 7 obligaties in Oxurion, resulterend in EUR 175.000 kapitaalverhoging. Oxurion richt zich op innovatieve geneesmiddelen voor ouderen Kapitaalverhoging Oxurion Atlas Special Opportunities, LLC Innovatieve Geneesmiddelen Ouderen
BRIEF published on 07/23/2025 at 18:05, 4 months 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
BRIEF published on 07/23/2025 at 18:05, 4 months 13 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
PRESS RELEASE published on 07/23/2025 at 18:00, 4 months 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding share threshold crossing under Belgian legislation Transparency Notification Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC Share Threshold
PRESS RELEASE published on 07/23/2025 at 18:00, 4 months 13 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop aandelen. Leuven biofarmaceutisch bedrijf België Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
BRIEF published on 07/22/2025 at 18:05, 4 months 14 days ago Oxurion NV reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Notification De Transparence Oxurion NV Opportunités Spéciales Atlas Législation Belge
BRIEF published on 07/22/2025 at 18:05, 4 months 14 days ago Oxurion NV Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Atlas Special Opportunities Oxurion NV Belgian Legislation
PRESS RELEASE published on 07/22/2025 at 18:00, 4 months 14 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding voting securities selling, crossing under 20% threshold Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Voting Securities
PRESS RELEASE published on 07/22/2025 at 18:00, 4 months 14 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC. Onder 20% drempel door verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
Published on 12/06/2025 at 00:25, 32 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 57 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 27 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 3 hours 12 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 22:15, 2 hours 41 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 45 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 59 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 6 hours 41 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 1 hour 57 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 57 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 57 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 57 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 39 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
